CLOSE

Benchmark Investments

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
30.64 0.36(1.19%) NAV as on 22 Nov 2024
-2.51 % 1 M
36.36 % 1 Y
18.45 % 3 Y

Growth Chart of the Scheme vis a vis benchmark

  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y

SCHEME DETAILS

Expenses Ratio :

2.28

As on 31 Oct, 2024
Age :

5 yrs 4 m

Since 10 07 ,2019
Exit Load :

1%

AUM :

881.52 Crs

Portfolio Price To Book Value :

7.79

Investing Style :

Large Growth

Min. Investment :

SIP 100 & Lumpsum 1000

Category :

sector funds

Fund Manager :

Dhaval Shah

Launch Date :

10-Jul-19

Scheme Benchmark :

NA

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

LATEST ASSET & PORTFOLIO ALLOCATION

as on Oct 31 ,2024
Others 6.37 %
Equity 93.63 %

TOP HOLDINGS

Sun Pharmaceutical Industries...14.39 %
Cipla Ltd.8.84 %
Torrent Pharmaceuticals Ltd.7.07 %
Apollo Hospitals Enterprise Ltd.5.89 %
Aurobindo Pharma Ltd.5.41 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs73.98
Hospital & Healthcare Services15.55
Business Support1.83
Insurance1.40
Chemicals0.87
See All Sectors

5-YEARS HISTORY

Financial Year2019-20202020-20212021-20222022-20232023-2024
NAV in Rs (as on 31-Mar-2024)9.9916.1218.2216.3626.45
Net Assets(Rs Crores) (as on 31-Mar-2024) 170.68 454.91 515.33 428.44 699.55
Scheme Returns(%)(Absolute)-0.1063.4912.40-10.2661.38
B'mark Returns(%)(Absolute)NANANANANA
Category Rank6/7555/7549/7570/7611/90

Quarterly Performance - Last 5 Years (Absolute Ret. In %)

Financial Year Q1 Q2 Q3 Q4
2024-20252.3419.54NANA
2023-202416.3812.0810.6412.03
2022-2023-10.766.09-0.58-4.61
2021-202216.324.91-0.15-7.23
2020-202125.1321.847.88-1.89

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity30.640.36(1.19%)NAV As on 22 Nov, 202410-Jul-2019Inception Date881.52AUM In Cr.36.36%1Y18.45%3Y23.76%5Y23.16%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity37.700.38(1.02%)NAV As on 22 Nov, 202413-Jul-2018Inception Date5,024.00AUM In Cr.46.52%1Y24.42%3Y30.00%5Y23.17%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity417.413.07(0.74%)NAV As on 22 Nov, 202414-Jul-1999Inception Date3,416.13AUM In Cr.43.05%1Y24.32%3Y28.73%5Y16.59%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity29.820.33(1.13%)NAV As on 22 Nov, 202428-Dec-2015Inception Date1,208.05AUM In Cr.38.56%1Y20.56%3Y26.40%5Y13.05%Since Inception

BENCHMARK INVESTMENTS

Benchmark Investments, 6 Sector II Shanti Niketan, Govindpura Bhopal, Bhopal-462023, India. +91-755-4938282/+91-9826310337 hello@benchmarkinvestments.in.
Downloads
Quick Links
Useful Links

Mutual fund and other investments are always subject to market risks. Please read all, Scheme Information Documents (SID), Key Information Memorandum (KIM), Addendums(if any) issued there to from time to time and any other related documents or information carefully before investing. Past performance is not indicative or assurance of future performance or returns. Please consider your specific investment requirements before choosing a fund.

For any grievances, investors can contact at: hello@benchmarkinvestments.in,  Tel: +91-755-4938282 / +91-9826310337.
©  Copyrights 2022 , Benchmark Investments | All Rights Reserved |  Designed, Developed & Content Powered by Accord Fintech Pvt Ltd